Author's posts
FDA authorizes Novavax coronavirus booster shot
Adults can receive the Novavax booster six months after completing their primary series of any coronavirus vaccine, including Moderna and Pfizer shots.
Updated coronavirus boosters now available for children as young as 5
The vaccines are designed to provide better protection against circulating variants, but adults have been slow to get the boosters.
Kids are flocking to flavored, disposable e-cigarettes, study finds
More than 2.5 million adolescents use the products, according to new CDC and FDA data.
What to know about the new ALS drug
The drug, Relyvrio, is only the third ALS treatment cleared by the Food and Drug Administration in almost three decades.
FDA approves first ALS drug in 5 years after pleas from patients
The newly approved therapy, called AMX0035, is designed to slow the disease by protecting nerve cells in the brain and spinal cord destroyed by ALS.
Experimental Alzheimer’s drug slows cognitive decline in trial, firms say
Makers of the drug have already applied to the Food and Drug Administration for accelerated approval for lecanemab, based on earlier-stage data.
FDA advisers recommend approval of controversial ALS drug
The vote increases the likelihood that the Food and Drug Administration will clear the first drug for the disease in five years.
Desperate patients want a new ALS drug. The FDA is not sure it works.
The therapy is the latest to raise questions about how the FDA assesses drugs for devastating diseases, such as ALS and Alzheimer’s.
What you need to know about fall booster shots of coronavirus vaccine
Reformulated coronavirus booster shots are on their way.
Coronavirus boosters targeting omicron get FDA blessing for fall push
The shots are expected to be available right after Labor Day.
